I am honored to serve on the advisory board for NuShores Biosciences LLC. I look forward to opportunities to contribute to your efforts with my experience and lessons learned in the areas of science – technology planning and commercialization, and to assist in the clinical aspects to make it available to patients as soon as possible.

The NuShores group has assembled a very strong development team under Dr. Biris and the operational depth needed to bring their novel materials to the market.  I am very excited to be contributing to NuShores and Alex’ team.

I am delighted to be working with such a wonderful team on lifechanging technologies and applications.  It is an honor to be along for the journey.

The opportunity to serve on the board of NuShores is exciting and thought-provoking.  As an active member of the scientific community with a specific interest in orthopedics, the ongoing research is especially relevant and exciting for me.  I am delighted to have to opportunity to help such a robust and creative group move their technology and research efforts forward

It is a rare opportunity to be able to support the historic scientific discoveries licensed to NuShores from UA Little Rock that will have a significant positive impact on public health and clinical practices.  I am blessed to be able to participate with NuShores team in maturing such scientific breakthroughs to commercial success

I am very excited to work with the team at NuShores in the development of an enabling technology in tissue regeneration.  I have worked with the group for some time now and have the greatest respect for their approach to the challenge and the quality of their research.  I believe that the rigor behind their work is world class and will be regarded as a new standard of care in repairing bone loss.

I am pleased to serve on the NuShores’ Advisory Board and look forward to contributing to their venture’s product successes.  There is a need for their innovative NuCress™ bone void filler that has potential use in my areas of medical practice.  I look forward to working with the NuShores team in accomplishing the scientific, regulatory and development milestones to make such a product available to physicians and their patients